Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
This drug takes a dual-action approach by targeting two different hormonal pathways involved in appetite and weight regulation: the GLP-1 and amylin pathways
These compounds are typically employed for their growth hormone-releasing properties, yet recent research indicates a compelling secondary benefit: the indirect enhancement of hair follicle activity via increased insulin-like growth factor 1 (IGF-1) availability
The most prevalent gastrointestinal adverse effects include: Nausea (37-43% of patients, the most common side effect) Diarrhea (24-30% of patients) Vomiting (19-25% of patients) Constipation (17-24% of patients) Abdominal pain (11-20% of patients) Dyspepsia or indigestion (10-11% of patients) Decreased appetite (reported as a separate effect) It's important to note that while some patients experience increased bowel movements or diarrhea, others develop constipationhighlighting the variable nature of tirzepatide's effects on individual digestive systems
Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M et al
GLP-1 Recipes Free, high-protein recipes built for a smaller appetite on GLP-1 medication Ozempic, Wegovy, Mounjaro and Zepbound
US$ 21.24
US$ 22.83
US$ 24.62
US$ 28.34
US$ 26.20
US$ 27.00
US$ 24.17
US$ 27.14
